Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: Photo/Multimedia, Product/Service, Award

BSI Wins Best Biotech Startup Business of the Year 2022 Award

Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has won the "Best Biotech Startup Business of the Year 2022" Award from the World BioProtection Forum and was selected finalist for two more categories. This Award was presented to BSI Senior Vice President Latin America Diego Ibańez who also was one of the distinguished speakers at the main event, held on May 23 in Birmingham, UK.

An international panel of 20 senior agricultural executives and research scientists evaluated dozens of successful projects based on a point system. The judges' collective decision to award this honor to BSI was based on the company's discovery, innovativeness, scientific value and successful commercialization of its new biofungicide Quillibrium® for fruit and vegetable growers worldwide. The judges also selected BSI as one of the ?Finalists' for the Most Innovative Research Project and the Best Collaboration of the Year for its strong partnership with Syngenta in Latin America.

BSI scientists discovered that extracts of a tissue cultured tree native to Chile, the Quillaja saponaria, produce a powerful biofungicide which protects a wide variety of fruits and vegetables against a broad spectrum of plant diseases. An early stumbling block to commercial development was the Chilean deforestation law which strictly forbids the cutting down of Quillaja saponaria trees. BSI overcame this obstacle by innovating and patenting a unique method of growing these trees right in the company's own laboratories, and then extracting the active ingredients while the trees are in vitro... baby trees. The same technology also fuels BSI's pipeline of new biopesticide candidates that are based on a number of plant species, which ensures virtually unlimited supply of raw materials and highly consistent active ingredients that have prevented traditional botanicals from its true potential... until now.

The new botanical-based biofungicide Quillibrium is being used successfully throughout Chile and Peru on a wide variety of fruits and vegetables through its distributor Syngenta. Quillibrium awaits regulatory approval in Mexico and the USA, and will soon initiate registration in additional countries to expand its global footprint.

BSI CEO Gastón Salinas declared, "The BSI team is honored to receive the Best Biotech Startup of the Year Award from the World BioProtection Forum. BSI is building strong foundations to deliver the world's most advanced botanical biopesticides for fruit and vegetable growers worldwide, starting with Quillibrium. We are creating a powerful product pipeline for the next generation of botanical-based products." Gastón Salinas will be keynote speaker at Biocontrol Latam on August 16th in Santiago, Chile.

About BSI
BSI, a Delaware Corporation, has a proprietary R&D platform for truly sustainable and improved production of consistent and high-quality Advanced Botanical Materials (ABM). ABM-01 is the first ABM produced by the company, based on a tissue cultured plant called Quillaja saponaria. ABM-01 is the active ingredient used in two gold standard products, BSI's biopesticide Quillibrium® and the adjuvant QS-21, used in modern vaccine development. To learn more visit us at www.botanical-solution.com.

These press releases may also interest you

at 17:28
This summer, (RED), the organization co-founded by Bono and Bobby Shriver, is launching '(LIVE SUMMER)', a campaign to fight AIDS and COVID-19. There are many ways to be (RED) - from what's in your makeup kit to...

at 17:21
The American College of Preventive Medicine (ACPM) embraces the recent news from the Accreditation Council for Graduate Medical Education (ACGME) that Public Health and General Preventive Medicine will now be...

at 17:03
Neptune Wellness Solutions Inc. ("Neptune" or the "Company") , a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced a delay of the filing of its...

at 16:50
Pfizer Inc. and BioNTech SE today announced a new vaccine supply agreement with the U.S. government to support the continued fight against COVID-19. Under the agreement, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg)....

at 16:40
Field Trip Health Ltd. ("Field Trip" or the "Corporation"), a global leader in the development and delivery of psychedelic therapies, today announces that on June 29, 2022, it...

at 16:35
Life Edit Therapeutics Inc., an ElevateBio company focused on next-generation genome editing technologies and therapeutics, today announced the appointment of Joy A. Cavagnaro, Ph.D., DABT, Fellow ATS, RAC, FRAPS, to its Scientific Advisory Board...

News published on 26 may 2022 at 00:40 and distributed by: